Research progress of artificial intelligence in high-throughput drug screening. [PDF]
Liu X +8 more
europepmc +1 more source
dECM bioinks for 3D bioprinted tumor models: Advances, challenges, and drug screening. [PDF]
Chen Q, Zhou R, Xu Q, Li Z, Tao J.
europepmc +1 more source
Training toolkit on drug policy advocacy.
This training toolkit has been developed by the International Drug Policy Consortium (IDPC) and the Eurasian Harm Reduction Network (EHRN) to build the capacity of civil society organisations for engaging with, and influencing, drug policy making ...
core
Development of gelatin based cryogel model for drug screening application in osteosarcoma. [PDF]
Mandeda Madaiah P +2 more
europepmc +1 more source
‘Civil society involvement in drug policy’ webinar.
On 30th November 2018, Ana Liffey Drug Project hosted a webinar about Civil Society Involvement in Drug Policy. The event included interviews with: Anna Quigley (CityWide) Tony Duffin (Ana Liffey Drug Project) Aoife Frances (National Family Support ...
core
Preclinical animal models for onchocerciasis and loiasis: A systematic review of applications in drug screening. [PDF]
Ayiseh RB +4 more
europepmc +1 more source
A zebrafish luminescent biosensor for kidney tubulopathy, metal toxicity and drug screening. [PDF]
Lai H +8 more
europepmc +1 more source
Bioprinted Bladder Cancer Organoids Model System for Prediction of Chemotherapy Response and Drug Screening. [PDF]
Bissette RG +5 more
europepmc +1 more source
Saudi Patient-Derived Brain and Intracranial Explanted Tumor Cells: Isolation, Growth, and Anticancer Drug Screening. [PDF]
Alsubaie SM +7 more
europepmc +1 more source

